208 related articles for article (PubMed ID: 20375793)
1. Endothelial nitric oxide synthase expression in gestational trophoblastic diseases.
Barut A; Harma M; Arikan I; Harma MI; Barut F
Int J Gynecol Cancer; 2010 Apr; 20(3):337-40. PubMed ID: 20375793
[TBL] [Abstract][Full Text] [Related]
2. Endothelial nitric oxide synthase immunoreactivity in early gestation and in trophoblastic disease.
Ariel I; Hochberg A; Shochina M
J Clin Pathol; 1998 Jun; 51(6):427-31. PubMed ID: 9771440
[TBL] [Abstract][Full Text] [Related]
3. Expression of laminin receptor 1 in gestational trophoblastic diseases and normal placenta and its relationship with the development of postmolar tumors.
Kurdoglu M; Bayram I; Kolusari A; Erten R; Adali E; Bulut G; Yildizhan R; Kurdoglu Z; Kucukaydin Z; Sahin HG
Gynecol Oncol; 2009 Aug; 114(2):306-9. PubMed ID: 19481788
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
5. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
[TBL] [Abstract][Full Text] [Related]
6. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of endothelial nitric oxide synthase and C-kit in the placenta of complete hydatidiform mole.
Ahmed A; Lacson A; Gilbert-Barness E
Fetal Pediatr Pathol; 2005; 24(3):141-7. PubMed ID: 16338875
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern alterations of the serine protease HtrA1 in normal human placental tissues and in gestational trophoblastic diseases.
Marzioni D; Quaranta A; Lorenzi T; Morroni M; Crescimanno C; De Nictolis M; Toti P; Muzzonigro G; Baldi A; De Luca A; Castellucci M
Histol Histopathol; 2009 Oct; 24(10):1213-22. PubMed ID: 19688690
[TBL] [Abstract][Full Text] [Related]
9. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression.
Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM
Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755
[TBL] [Abstract][Full Text] [Related]
10. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma.
Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P
Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465
[TBL] [Abstract][Full Text] [Related]
11. Differential expression patterns of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) -1, -4, -5, and -14 in human placenta and gestational trophoblastic diseases.
Lee SY; Lee HS; Gil M; Kim CJ; Lee YH; Kim KR; Park CS
Arch Pathol Lab Med; 2014 May; 138(5):643-50. PubMed ID: 24786121
[TBL] [Abstract][Full Text] [Related]
12. Expression of TGF-beta signaling proteins in normal placenta and gestational trophoblastic disease.
Xuan YH; Choi YL; Shin YK; Ahn GH; Kim KH; Kim WJ; Lee HC; Kim SH
Histol Histopathol; 2007 Mar; 22(3):227-34. PubMed ID: 17163397
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
Persaud V; Ganjei P; Nadji M
West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
[TBL] [Abstract][Full Text] [Related]
14. The expression of human chorionic gonadotropin/human luteinizing hormone receptors in human gestational trophoblastic neoplasms.
Lei ZM; Rao CV; Ackerman DM; Day TG
J Clin Endocrinol Metab; 1992 Jun; 74(6):1236-41. PubMed ID: 1592864
[TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
16. Pathology of gestational trophoblastic diseases.
Cheung AN
Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):849-68. PubMed ID: 14614885
[TBL] [Abstract][Full Text] [Related]
17. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
18. Expression of HOX gene products in normal and abnormal trophoblastic tissue.
Amesse LS; Moulton R; Zhang YM; Pfaff-Amesse T
Gynecol Oncol; 2003 Sep; 90(3):512-8. PubMed ID: 13678718
[TBL] [Abstract][Full Text] [Related]
19. [Gestational trophoblastic disease, Villous gestational trophoblastic disease].
Vogel M; Horn LC
Pathologe; 2004 Jul; 25(4):269-79. PubMed ID: 15197483
[TBL] [Abstract][Full Text] [Related]
20. Detection of the alpha-subunit of inhibin in trophoblastic neoplasia.
Pelkey TJ; Frierson HF; Mills SE; Stoler MH
Hum Pathol; 1999 Jan; 30(1):26-31. PubMed ID: 9923923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
